SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-039625
Filing Date
2021-06-10
Accepted
2021-06-10 18:41:42
Documents
1
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 8002
  Complete submission text file 0001209191-21-039625.txt   9461
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 98195-2141
Business Address
CHURCH KEVIN (Reporting) CIK: 0001822499 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39503 | Film No.: 211009394